Dopamine D2/D3 receptors drugs for Parkinson's Disease

2 tracked Dopamine D2/D3 receptors drugs in the Parkinson's Disease race. The class explanation lives on the Dopamine D2/D3 receptors page; the full indication pipeline across every mechanism is on the Parkinson's Disease page.

1 approved / phase 41 US approval withdrawn

The roster

← all Dopamine D2/D3 receptors drugs